Protoporphyrin IX-loaded albumin nanoparticles reverse cancer chemoresistance by enhancing intracellular reactive oxygen species

Nanomedicine. 2023 Jul:51:102688. doi: 10.1016/j.nano.2023.102688. Epub 2023 Apr 28.

Abstract

Chemoresistance is the main cause of chemotherapy failure in ovarian cancer (OC). The enhanced scavenging of reactive oxygen species (ROS) by the thioredoxin system resulted in insufficient intracellular concentrations of effective ROS, leading to chemoresistance. To induce OC cell apoptosis by enhancing intracellular ROS levels, protoporphyrin IX (PpIX) and albumin-bound PTX nanoparticles (APNP) were utilized to fabricate APNP-PpIX nanoparticles. APNP-PpIX effectively generated ROS and increased the effective ROS concentration in chemoresistant cancer cells. The in vitro and in vivo experiments confirmed the effective inhibition of APNP-PpIX on chemoresistant OC cell proliferation and tumor formation. APNP-PpIX significantly improved the effectiveness of chemotherapy and photodynamic therapy, thus providing a new approach for the clinical treatment of chemoresistant OC.

Keywords: Chemoresistance; Nanoparticle; Ovarian cancer; Protoporphyrin; Thioredoxin.

MeSH terms

  • Cell Line, Tumor
  • Drug Resistance, Neoplasm
  • Humans
  • Nanoparticles*
  • Neoplasms*
  • Photochemotherapy* / methods
  • Photosensitizing Agents / pharmacology
  • Reactive Oxygen Species

Substances

  • Photosensitizing Agents
  • Reactive Oxygen Species
  • protoporphyrin IX